Table 4.
Multiple comparison of BMI, WC, TC, TG, LDL-C and HDL-C across the study groups
Multiple comparisons: Tukey HSD | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dependent variables | Mean difference (I–J) | Std. error | Sig. | 95% confidence interval | Mean difference (I–J) | Std. error | Sig. | 95% confidence interval | |||
(I) Group | (J) Group | Lower bound | Upper bound | Lower bound | Upper bound | ||||||
Changes in BMI | Change in WC | ||||||||||
Vit Da | Vit D + PA | 1.4* | .45 | .029 | .09 | 2.72 | 1.19 | .99 | .831 | − 1.6 | 4.07 |
Vit C | .74 | .43 | .512 | − .50 | 1.99 | 1.18 | .94 | .802 | − 1.5 | 3.91 | |
Vit C + PA | .79 | .44 | .473 | − .48 | 2.08 | 4.17* | .97 | .001 | 1.3 | 6.98 | |
Placebo | .16 | .43 | .991 | − 1.09 | 1.42 | 1.35 | .95 | .714 | − 1.3 | 4.11 | |
Placebo + PAf | .63 | .44 | .722 | − .66 | 1.93 | 3.54* | .98 | .006 | .70 | 6.39 | |
Vit Cc | Vit D + PA | .66 | .44 | .675 | − .63 | 1.95 | .007 | .97 | 1.01 | − 2.8 | 2.83 |
Vit C + PA | .05 | .43 | 1.04 | − 1.20 | 1.31 | 2.98* | .95 | .021 | .22 | 5.74 | |
Placebo | − .57 | .42 | .755 | − 1.81 | .65 | .16 | .93 | 1.03 | − 2.52 | 2.86 | |
Placebo + PA | − .11 | .44 | 1.01 | − 1.38 | 1.16 | 2.36 | .96 | .142 | − .43 | 5.15 | |
Vit D + PAb | Vit C + PA | − .60 | .45 | .772 | − 1.93 | .72 | 2.97* | 1.00 | .041 | .07 | 5.88 |
Placebo | − 1.23 | .45 | .074 | − 2.54 | .06 | .16 | .98 | 1.01 | − 2.68 | 3.01 | |
Placebo + PA | − .77 | .46 | .551 | − 2.11 | .56 | 2.35 | 1.01 | .192 | − .58 | 5.29 | |
Vit C + PAd | Placebo | − .63 | .43 | .705 | − 1.90 | .64 | − 2.81* | .96 | .041 | − 5.60 | − .034 |
Placebo + PA | − .16 | .45 | .998 | − 1.47 | 1.14 | − .62 | .99 | .987 | − 3.49 | 2.24 | |
Placeboe | Placebo + PA | .46 | .44 | .901 | − .82 | 1.75 | 2.19 | .97 | .221 | − .62 | 5.00 |
Change in TC | Change in TG | ||||||||||
Vit Da | Vit D + PA | − .047 | 8.33 | 1.00 | − 24.15 | 24.05 | 10.96 | 11.48 | .931 | − 22.23 | 44.16 |
Vit C | − 18.38 | 7.89 | .190 | − 41.21 | 4.44 | 26.86 | 10.87 | .141 | − 4.59 | 58.31 | |
Vit C + PA | − 9.86 | 8.14 | .830 | − 33.40 | 13.66 | 29.52 | 11.21 | .096 | − 2.89 | 61.95 | |
Placebo | − 23.92* | 7.97 | .037 | − 46.97 | − .86 | − 6.64 | 10.98 | .990 | − 38.40 | 25.10 | |
Placebo + PAf | − 3.72 | 8.23 | .998 | − 27.53 | 20.08 | 10.67 | 11.34 | .935 | − 22.12 | 43.47 | |
Vit Cc | Vit D + PA | 18.33 | 8.18 | .227 | − 5.33 | 42.00 | − 15.89 | 11.27 | .721 | − 48.49 | 16.70 |
Vit C + PA | 8.51 | 7.98 | .894 | − 14.57 | 31.60 | 2.66 | 11.00 | 1.00 | − 29.14 | 34.47 | |
Placebo | − 5.53 | 7.81 | .981 | − 28.13 | 17.059 | − 33.51* | 10.76 | .027 | − 64.63 | − 2.38 | |
Placebo + PA | 14.65 | 8.08 | .461 | − 8.71 | 38.02 | − 16.18 | 11.13 | .694 | − 48.37 | 16.00 | |
Vit D + PAb | Vit C + PA | − 9.82 | 8.42 | .852 | − 34.16 | 14.52 | 18.56 | 11.60 | .600 | − 14.97 | 52.09 |
Placebo | − 23.8* | 8.25 | .050 | − 47.74 | .005 | − 17.61 | 11.37 | .634 | − 50.50 | 15.27 | |
Placebo + PA | − 3.67 | 8.51 | .998 | − 28.28 | 20.92 | − .29 | 11.72 | 1.00 | − 34.19 | 33.60 | |
Vit C + PAd | Placebo | − 14.05 | 8.06 | .506 | − 37.35 | 9.25 | − 36.17* | 11.10 | .017 | − 68.28 | − 4.07 |
Placebo + PA | 6.14 | 8.32 | .977 | − 17.91 | 30.19 | − 18.85 | 11.46 | .571 | − 51.98 | 14.28 | |
Placeboe | Placebo + PA | 20.19 | 8.15 | .139 | − 3.38 | 43.77 | 17.32 | 11.23 | .638 | − 15.15 | 49.80 |
Change in LDL-C | Change in HDL-C | ||||||||||
Vit Da | Vit D + PA | − 2.36 | 8.68 | 1.00 | − 27.46 | 22.74 | .60 | 4.03 | 1.00 | − 11.07 | 12.27 |
Vit C | − 23.47* | 8.22 | .055 | − 47.25 | .30 | − 1.39 | 3.82 | .992 | − 12.45 | 9.66 | |
Vit C + PA | − 12.65 | 8.47 | .669 | − 37.17 | 11.85 | − 15.57* | 3.94 | .002 | − 26.97 | − 4.17 | |
Placebo | − 21.99 | 8.30 | .093 | − 46.00 | 2.01 | − 2.96 | 3.86 | .972 | − 14.13 | 8.19 | |
Placebo + PAf | − 5.99 | 8.57 | .982 | − 30.79 | 18.79 | .68 | 3.98 | 1.00 | − 10.84 | 12.22 | |
Vit Cc | Vit D + PA | 21.11 | 8.52 | .138 | − 3.53 | 45.76 | 2.0 | 3.96 | .994 | − 9.46 | 13.46 |
Vit C + PA | 10.81 | 8.31 | .784 | − 13.23 | 34.86 | − 14.18* | 3.86 | .005 | − 25.36 | − 2.99 | |
Placebo | 1.481 | 8.13 | 1.00 | − 22.05 | 25.01 | − 1.57 | 3.78 | .998 | − 12.51 | 9.37 | |
Placebo + PA | 17.47 | 8.41 | .306 | − 6.85 | 41.81 | 2.08 | 3.91 | .995 | − 9.23 | 13.40 | |
Vit D + PAb | Vit C + PA | − 10.29 | 8.77 | .848 | − 35.65 | 15.05 | − 16.18* | 4.07 | .002 | − 27.97 | − 4.38 |
Placebo | − 19.63 | 8.60 | .208 | − 44.50 | 5.23 | − 3.57 | 4.00 | .941 | − 15.13 | 7.99 | |
Placebo + PA | − 3.63 | 8.86 | .998 | − 29.26 | 21.99 | .083 | 4.12 | 1.00 | − 11.83 | 12.00 | |
Vit C + PAd | Placebo | − 9.33 | 8.39 | .876 | − 33.61 | 14.93 | 12.60* | 3.90 | .012 | 1.31 | 23.89 |
Placebo + PA | 6.65 | 8.66 | .972 | − 18.39 | 31.71 | 16.26* | 4.03 | .001 | 4.61 | 27.91 | |
Placeboe | Placebo + PA | 15.99 | 8.49 | .417 | − 8.56 | 40.55 | 3.65 | 3.95 | .931 | − 7.76 | 15.07 |
Data are mean ± standard Error (SE)
PA, physical activity; BMI, body mass index; WC, waist circumferences; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol
* The mean difference is significant at the .05 level
aReceiving 2000 IU vitamin D per day
bReceiving 2000 IU vitamin D per day plus 30 min endurance physical activity
cReceiving 500 mg vitamin C per day
dReceiving 500 mg vitamin C per day plus 30 min endurance physical activity
eReceiving one placebo per day
fReceiving one placebo per day plus 30 min endurance physical activity
gObtained from ANOVA, Tukey method